Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial.

Persaud N, Bedard M, Boozary AS, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani MM, Manns BJ, Martin D, Morgan SG, Oh PI, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A; Carefully Selected and Easily Accessible at No Charge Medicines (CLEAN Meds) Study Team.

JAMA Intern Med. 2019 Oct 7. doi: 10.1001/jamainternmed.2019.4472. [Epub ahead of print]

2.

Microplastic accumulation and biomagnification in a coastal marine reserve situated in a sparsely populated area.

Saley AM, Smart AC, Bezerra MF, Burnham TLU, Capece LR, Lima LFO, Carsh AC, Williams SL, Morgan SG.

Mar Pollut Bull. 2019 Sep;146:54-59. doi: 10.1016/j.marpolbul.2019.05.065. Epub 2019 Jun 6.

PMID:
31426191
3.

Should national pharmacare apply a value-based insurance design?

Yeung K, Morgan SG.

CMAJ. 2019 Jul 22;191(29):E811-E815. doi: 10.1503/cmaj.181721. No abstract available.

PMID:
31332049
4.

Photoprotective benefits of pigmentation in the transparent plankton community: a comparative species experimental test.

Bashevkin SM, Christy JH, Morgan SG.

Ecology. 2019 May;100(5):e02680. doi: 10.1002/ecy.2680. Epub 2019 Apr 5.

PMID:
30838643
5.

How to pay for national pharmacare.

Wolfson MC, Morgan SG.

CMAJ. 2018 Nov 26;190(47):E1384-E1388. doi: 10.1503/cmaj.180897. No abstract available.

6.

Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis.

Kolhatkar A, Cheng L, Morgan SG, Goldsmith LJ, Dhalla IA, Holbrook AM, Law MR.

CMAJ Open. 2018 Nov 19;6(4):E544-E550. doi: 10.9778/cmajo.20180063. Print 2018 Oct-Dec.

7.

Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.

Brandt J, Shearer B, Morgan SG.

J Pharm Policy Pract. 2018 Nov 7;11:28. doi: 10.1186/s40545-018-0154-x. eCollection 2018. Review.

8.

Testing the intermittent upwelling hypothesis: reply.

Shanks AL, Morgan SG.

Ecology. 2019 Mar;100(3):e02516. doi: 10.1002/ecy.2516. Epub 2019 Jan 22. No abstract available.

PMID:
30204932
9.

An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries.

Morgan SG, Good CB, Leopold C, Kaltenboeck A, Bach PB, Wagner A.

Health Policy. 2018 Sep;122(9):1012-1017. doi: 10.1016/j.healthpol.2018.07.005. Epub 2018 Jul 21.

PMID:
30041827
10.

New generic pricing scheme maintains high prices and risks of shortages.

Morgan SG, Persaud N.

CMAJ. 2018 Apr 9;190(14):E410-E411. doi: 10.1503/cmaj.180197. No abstract available.

11.

The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey.

Law MR, Cheng L, Kolhatkar A, Goldsmith LJ, Morgan SG, Holbrook AM, Dhalla IA.

CMAJ Open. 2018 Feb 5;6(1):E63-E70. doi: 10.9778/cmajo.20180008.

12.

Erectile Dysfunction Medications and Treatment for Cardiometabolic Risk Factors: A Pharmacoepidemiologic Study.

Skeldon SC, Cheng L, Morgan SG, Detsky AS, Goldenberg SL, Law MR.

J Sex Med. 2017 Dec;14(12):1597-1605. doi: 10.1016/j.jsxm.2017.10.063.

PMID:
29198514
13.

The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.

Worthington HC, Cheng L, Majumdar SR, Morgan SG, Raymond CB, Soumerai SB, Law MR.

Implement Sci. 2017 Nov 25;12(1):141. doi: 10.1186/s13012-017-0671-z.

14.

Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application.

Goldsmith LJ, Kolhatkar A, Popowich D, Holbrook AM, Morgan SG, Law MR.

Soc Sci Med. 2017 Dec;194:51-59. doi: 10.1016/j.socscimed.2017.10.007. Epub 2017 Oct 9.

PMID:
29065312
15.

Evaluating the effects of Quebec's private-public drug insurance system.

Morgan SG, Gagnon MA, Charbonneau M, Vadeboncoeur A.

CMAJ. 2017 Oct 10;189(40):E1259-E1263. doi: 10.1503/cmaj.170726. Review. No abstract available.

16.

Planktonic Subsidies to Surf-Zone and Intertidal Communities.

Morgan SG, Shanks AL, MacMahan JH, Reniers AJHM, Feddersen F.

Ann Rev Mar Sci. 2018 Jan 3;10:345-369. doi: 10.1146/annurev-marine-010816-060514. Epub 2017 Aug 28. Review.

PMID:
28846492
17.

The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries.

Morgan SG, Yau B, Lumpkin MM.

PLoS One. 2017 Aug 15;12(8):e0182742. doi: 10.1371/journal.pone.0182742. eCollection 2017.

18.

Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage.

Morgan SG, Leopold C, Wagner AK.

CMAJ. 2017 Jun 12;189(23):E794-E799. doi: 10.1503/cmaj.161481.

19.

A rapidly changing global medicines environment: How adaptable are funding decision-making systems?

Leopold C, Morgan SG, Wagner AK.

Health Policy. 2017 Jun;121(6):637-643. doi: 10.1016/j.healthpol.2017.04.002. Epub 2017 Apr 10.

PMID:
28449884
20.

Patterns, predictors and persistence of chronic sedative use: a population-based observational study of older adults in British Columbia, Canada.

Morgan SG, Weymann D.

Eur J Clin Pharmacol. 2017 Aug;73(8):1001-1008. doi: 10.1007/s00228-017-2253-z. Epub 2017 Apr 24.

PMID:
28435984
21.

The effects of catastrophic drug plan deductibles on older women's use of cardiovascular medicines: a retrospective cohort study.

Morgan SG, Gladstone EJ, Weymann D, Khan N.

CMAJ Open. 2017 Mar 3;5(1):E198-E204. doi: 10.9778/cmajo.20160145. eCollection 2017 Jan-Mar.

22.

Long-term sedative use among community-dwelling adults: a population-based analysis.

Weymann D, Gladstone EJ, Smolina K, Morgan SG.

CMAJ Open. 2017 Mar 3;5(1):E52-E60. doi: 10.9778/cmajo.20160056. eCollection 2017 Jan-Mar.

23.

Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.

Morgan SG, Li W, Yau B, Persaud N.

CMAJ. 2017 Feb 27;189(8):E295-E302. doi: 10.1503/cmaj.161082. Erratum in: CMAJ. 2017 Apr 3;189(13):E511.

24.

Payers' experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia.

Morgan SG, Vogler S, Wagner AK.

Health Policy. 2017 Apr;121(4):354-362. doi: 10.1016/j.healthpol.2017.02.002. Epub 2017 Feb 16.

25.
26.

Variation in the abundance of Pseudo-nitzschia and domoic acid with surf zone type.

Shanks AL, Morgan SG, MacMahan J, Reniers AJ, Kudela R, Jarvis M, Brown J, Fujimura A, Ziccarelli L, Griesemer C.

Harmful Algae. 2016 May;55:172-178. doi: 10.1016/j.hal.2016.03.004. Epub 2016 Mar 25.

PMID:
28073530
27.

Patterns and trends in long-term opioid use for non-cancer pain in British Columbia, 2005-2012.

Smolina K, Gladstone EJ, Rutherford K, Morgan SG.

Can J Public Health. 2016 Dec 27;107(4-5):e404-e409. doi: 10.17269/cjph.107.5413.

PMID:
28026706
28.

Shifts in intertidal zonation and refuge use by prey after mass mortalities of two predators.

Gravem SA, Morgan SG.

Ecology. 2017 Apr;98(4):1006-1015. doi: 10.1002/ecy.1672.

29.

Universal prescription drug coverage in Canada: Long-promised yet undelivered.

Morgan SG, Boothe K.

Healthc Manage Forum. 2016 Nov;29(6):247-254. Epub 2016 Oct 15. Review.

30.

Surfzone hydrodynamics as a key determinant of spatial variation in rocky intertidal communities.

Morgan SG, Shanks AL, Fujimura AG, Reniers AJ, MacMahan J, Griesemer CD, Jarvis M, Brown J.

Proc Biol Sci. 2016 Oct 12;283(1840). pii: 20161017.

31.

Seasonal changes in fish assemblage structure at a shallow seamount in the Gulf of California.

Jorgensen SJ, Klimley AP, Muhlia-Melo A, Morgan SG.

PeerJ. 2016 Sep 6;4:e2357. doi: 10.7717/peerj.2357. eCollection 2016.

32.

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.

Morgan SG, Gagnon MA, Mintzes B, Lexchin J.

Healthc Policy. 2016 Aug;12(1):18-36.

33.

Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study.

Morgan SG, Hunt J, Rioux J, Proulx J, Weymann D, Tannenbaum C.

CMAJ Open. 2016 Jun 22;4(2):E346-51. doi: 10.9778/cmajo.20150131. eCollection 2016 Apr-Jun.

34.

Inverse approach to estimating larval dispersal reveals limited population connectivity along 700 km of wave-swept open coast.

Hameed SO, White JW, Miller SH, Nickols KJ, Morgan SG.

Proc Biol Sci. 2016 Jun 29;283(1833). pii: 20160370. doi: 10.1098/rspb.2016.0370.

35.

The association between domperidone and ventricular arrhythmia in the postpartum period.

Smolina K, Mintzes B, Hanley GE, Oberlander TF, Morgan SG.

Pharmacoepidemiol Drug Saf. 2016 Oct;25(10):1210-1214. doi: 10.1002/pds.4035. Epub 2016 Jun 14.

PMID:
27296864
36.

Postpartum domperidone use in British Columbia: a retrospective cohort study.

Smolina K, Morgan SG, Hanley GE, Oberlander TF, Mintzes B.

CMAJ Open. 2016 Jan 12;4(1):E13-9. doi: 10.9778/cmajo.20150067. eCollection 2016 Jan-Mar.

37.

Sex differences in the risk of receiving potentially inappropriate prescriptions among older adults.

Morgan SG, Weymann D, Pratt B, Smolina K, Gladstone EJ, Raymond C, Mintzes B.

Age Ageing. 2016 Jul;45(4):535-42. doi: 10.1093/ageing/afw074. Epub 2016 May 5.

38.

Toward better prescription drug surveillance in Canada.

Smolina K, Persaud N, Morgan SG.

CMAJ. 2016 Aug 9;188(11):E252-E253. doi: 10.1503/cmaj.151120. Epub 2016 May 2. No abstract available.

39.

High-Cost Users of Prescription Drugs: A Population-Based Analysis from British Columbia, Canada.

Weymann D, Smolina K, Gladstone EJ, Morgan SG.

Health Serv Res. 2017 Apr;52(2):697-719. doi: 10.1111/1475-6773.12492. Epub 2016 Apr 18.

40.

Determinants of trends in prescription opioid use in British Columbia, Canada, 2005-2013.

Smolina K, Gladstone E, Morgan SG.

Pharmacoepidemiol Drug Saf. 2016 May;25(5):553-9. doi: 10.1002/pds.3989. Epub 2016 Mar 7.

PMID:
26947145
41.

Postpartum Hemorrhage and Use of Serotonin Reuptake Inhibitor Antidepressants in Pregnancy.

Hanley GE, Smolina K, Mintzes B, Oberlander TF, Morgan SG.

Obstet Gynecol. 2016 Mar;127(3):553-61. doi: 10.1097/AOG.0000000000001200.

PMID:
26855096
42.

Postmarket policy considerations for biosimilar oncology drugs.

Renwick MJ, Smolina K, Gladstone EJ, Weymann D, Morgan SG.

Lancet Oncol. 2016 Jan;17(1):e31-8. doi: 10.1016/S1470-2045(15)00381-2. Epub 2015 Dec 23. Review.

PMID:
26758759
43.

Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths.

Gladstone E, Smolina K, Morgan SG, Fernandes KA, Martins D, Gomes T.

CMAJ. 2016 Mar 1;188(4):E67-E72. doi: 10.1503/cmaj.150349. Epub 2015 Nov 30.

44.

Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada.

Gladstone EJ, Smolina K, Weymann D, Rutherford K, Morgan SG.

Med Care. 2015 Nov;53(11):954-9. doi: 10.1097/MLR.0000000000000431.

PMID:
26465123
45.

Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women.

Smolina K, Ball L, Humphries KH, Khan N, Morgan SG.

Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):586-92. doi: 10.1161/CIRCOUTCOMES.115.001987. Epub 2015 Oct 13.

PMID:
26462876
46.

Trends and sex differences in prescription opioid deaths in British Columbia, Canada.

Gladstone EJ, Smolina K, Morgan SG.

Inj Prev. 2016 Aug;22(4):288-90. doi: 10.1136/injuryprev-2015-041604. Epub 2015 Jul 20.

PMID:
26195562
47.

A drug by any other name… generic and brand-name drugs are clinically equivalent.

Morgan SG.

J Prim Health Care. 2015 Jun 1;7(2):93. No abstract available.

PMID:
26125053
48.

When is dispersal for dispersal? Unifying marine and terrestrial perspectives.

Burgess SC, Baskett ML, Grosberg RK, Morgan SG, Strathmann RR.

Biol Rev Camb Philos Soc. 2016 Aug;91(3):867-82. doi: 10.1111/brv.12198. Epub 2015 Jun 26. Review.

49.

Impact of allowing pharmacists to independently renew prescriptions: A population-based study.

Law MR, Cheng L, Kratzer J, Morgan SG, Marra C, Lynd LD, Majumdar SR.

J Am Pharm Assoc (2003). 2015 Jul-Aug;55(4):398-404. doi: 10.1331/JAPhA.2015.14262.

PMID:
26115380
50.

Estimated cost of universal public coverage of prescription drugs in Canada.

Morgan SG, Law M, Daw JR, Abraham L, Martin D.

CMAJ. 2015 Apr 21;187(7):491-497. doi: 10.1503/cmaj.141564. Epub 2015 Mar 16.

Supplemental Content

Loading ...
Support Center